| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8956390 | Vaccine | 2018 | 8 Pages |
Abstract
A national immunization strategy based in Switch-to PCV13 was found to be good value for money and prevent additional burden of pneumococcal disease saving additional treatment costs, when compared with to Keep-PCV10 in Colombia, however additional criteria to decision making must be taken into account.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Carlos Castañeda-Orjuela, Fernando De la Hoz-Restrepo,